stockrow
Friday 6 November 2026
Export FOCL’s income statement to Excel — free account
FocalTherics
FOCL Healthcare Medical Distribution
- Revenue
- +38.9%
- EPS
- −129.4%
- Free cash flow
- +21.5%
- Total debt
- +366.8%
Quarter to June 2026, against a year earlier
4.17
0.17
−3.92%
Follow FOCL
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
2.50 | 1.88 | 1.75 | 1.39 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(52.67) | (46.92) | (50.84) | (21.77) | |
P/B ratio |
0.00 | 13.80 | 6.35 | 2.02 | |
Price to Tangible BV |
0.00 | 24.87 | 7.31 | 2.16 | |
EV/Sales |
2.74 | 2.01 | 1.78 | 1.30 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(16.35) | (10.62) | (7.63) | (5.73) | |
EV/FCF |
(11.13) | (7.15) | (5.40) | (4.15) | |
Quick Ratio |
0.88 | 0.94 | 0.99 | 0.94 | |
Current Ratio |
1.60 | 1.34 | 1.54 | 1.41 | |
Net Debt/EBITDA |
(2.64) | (1.50) | (0.34) | 0.92 | |
Debt/Assets |
53.79% | 34.34% | 28.46% | 9.85% | |
Debt/Equity |
(12.43) | 2.45 | 1.16 | 0.26 | |
Asset Turnover |
1.00 | 0.97 | 0.84 | 0.77 | |
Operating CF/Net income |
0.25 | 0.33 | 0.25 | 0.68 | |
Capex/Depreciation |
(1.25) | (1.04) | (0.51) | 0.00 | |
Research and Development Expense of Revenue |
17.55% | 14.58% | 7.72% | 15.03% | |
Selling, General and Administrative Expense of Revenue |
98.87% | 72.51% | 51.87% | 63.49% | |
Intangible Assets out of Total Assets |
0.03 | 0.06 | 0.03 | 0.04 | |
Share Based Compensation of Revenue |
6.48% | 1.70% | 8.36% | 0.00% | |
Graham Net Nets |
(0.10) | (0.08) | (0.02) | 0.09 | |
Graham Number |
1.41 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(19.88%) | (21.77%) | (23.40%) | (24.89%) | |
Free Cash Flow Yield |
(9.84%) | (14.97%) | (18.82%) | (22.61%) | |
Revenue per Share |
0.35 | 0.48 | 0.82 | 0.43 | |
Operating CF per Share |
(0.10) | (0.08) | (0.06) | (0.11) | |
Capex per Share |
(0.03) | (0.02) | (0.05) | (0.05) | |
Free Cash Flow per Share |
(0.13) | (0.10) | (0.11) | (0.16) | |
Cash per Share |
0.57 | 0.40 | 0.55 | 0.33 | |
Shareholders Equity per Share |
(0.09) | 0.27 | 0.52 | 0.73 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.09) | 0.27 | 0.52 | 0.73 | |
Free Cash Flow |
(4.95) | (3.90) | (4.17) | (5.92) | |
Working Capital |
22.17 | 12.86 | 20.02 | 15.19 | |
Capital Expenditures |
(1.25) | (0.93) | (1.75) | (1.98) | |
Net Current Asset Value |
(18.76) | (11.59) | (2.42) | 7.29 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.10 | 0.05 | 0.06 | 0.12 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
16.26 | 18.91 | 18.66 | 20.18 | |
Average Payables |
16.09 | 15.63 | 11.43 | 20.37 | |
Average Inventory |
13.27 | 16.40 | 13.49 | 19.80 | |
Average Assets |
77.49 | 76.50 | 84.20 | 80.11 | |
Average Common Equity |
29.19 | 36.86 | 47.93 | — |
Columns are period end dates · fundamentals updated 26 Oct 2026